SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals to sell Unit-VI located in Visakhapatnam for Rs 173.00 crore

17 Oct 2012 Evaluate

SMS Pharmaceuticals has considered and approved the sale consideration for Unit -VI situated at Plot No 28, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam, Andhra Pradesh (A.P.), as Rs 173.00 crore. The company has identified and finalized ‘Mylan Laboratories’ as buyer out of the proposals received.

The company has already received its board’s approval for the same at a meeting held on August 18, 2012.

SMS Pharmaceuticals is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and its intermediates. The company has six manufacturing facilities and two R&D facilities located in Andhra Pradesh.

SMS Pharmaceuticals Share Price

419.25 4.35 (1.05%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×